CASI Pharmaceuticals, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
In the following Press release, The company presented, “Data On Anti-Tumor Activity Of ENMD-2076 In Triple Negative Breast Cancer Animal Models In Poster Session At AACR-NCI-EORTC International Conference”. Read the full article.
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD. [Source: MarketWatch]
Company Website: http://www.casipharmaceuticals.com